Oncology Today offentlig
[search 0]
Mer

Download the App!

show episodes
 
Loading …
show series
 
Dr John Allan from Weill Cornell Medicine in New York City discusses the most important chronic lymphocytic leukemia studies presented at ASH 2022. CME information and select publications here.Av Research To Practice
  continue reading
 
Dr Matthew Lunning from the University of Nebraska Medical Center in Omaha, Nebraska, discusses the most important lymphoma studies presented at the 2022 ASH Annual Meeting. CME information and select publications here.Av Research To Practice
  continue reading
 
Dr Edward Garon from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles, California, discusses the management of NSCLC in patients who do not have actionable activating mutations. CME information and select publications here.Av Research To Practice
  continue reading
 
Dr Srdan Verstovsek from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses new data with myeloproliferative neoplasms presented at the 2022 ASH Annual Meeting. CME information and select publications here.Av Research To Practice
  continue reading
 
Dr Richard Stone from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses new data in acute myeloid leukemia and myelodysplastic syndromes presented at the 2022 ASH Annual Meeting. CME information and select publications here.Av Research To Practice
  continue reading
 
Dr Erica Mayer from the Dana-Farber Cancer Institute in Boston, Massachusetts and Dr Ruth O'Regan from the University of Rochester in Rochester, New York discuss new developments in ER-positive breast cancer. CME information and select publications here.Av Research To Practice
  continue reading
 
Dr Manish Shah from Weill Cornell Medicine in New York City discusses current approaches to the management of upper GI malignancies and the potential future role of novel therapies for patients with these cancers. CME information and select publications here.Av Research To Practice
  continue reading
 
Dr Scott Tagawa from Weill Cornell Medicine Sandra and Edward Meyer Cancer Center in New York, New York discusses current treatments and management strategies for metastatic urothelial bladder cancer. CME information and select publications here.Av Research To Practice
  continue reading
 
Dr Rachna Shroff from the University of Arizona Cancer Center in Tucson, Arizona, discusses data and the practical implications from key gastrointestinal cancer presentations made at recent major oncology conferences. CME information and select publications here.Av Research To Practice
  continue reading
 
Dr Rebecca Heist from Massachusetts General Hospital Cancer Center in Boston, Massachusetts discusses recent therapeutic advances in the management of MET-altered non-small cell lung cancer. CME information and select publications here.Av Research To Practice
  continue reading
 
Professor Sia Daneshmand from the USC/Norris Comprehensive Cancer Center in Los Angeles, California, discusses recent advances in and perspectives on the management of nonmetastatic urothelial bladder cancer. CME information and select publications here.Av Research To Practice
  continue reading
 
Dr Charles Powell from the Mount Sinai National Jewish Health Respiratory Institute in New York discusses the diagnosis and treatment of interstitial lung disease in patients receiving anticancer therapy. CME information and select publications here.Av Research To Practice
  continue reading
 
Dr Asim Farooq from The University of Chicago Medical Center in Chicago, Illinois, discusses common ocular toxicities associated with anticancer agents, including antibody-drug conjugates and EGFR, ALK, MEK and BRAF inhibitors. CME information and select publications here.Av Research To Practice
  continue reading
 
Dr Ezra Cohen from the Moores Cancer Center at UC San Diego Health in La Jolla, California, discusses key abstracts presented in head, neck and thyroid cancers at the 2022 ASCO annual meeting. CME information and select publications here.Av Research To Practice
  continue reading
 
Dr Jeffrey Bradley from the Emory University School of Medicine in Atlanta, Georgia, and Dr David Spigel from the Sarah Cannon Research Institute in Nashville, Tennessee, discuss the past, present and future management of unresectable Stage III non-small cell lung cancer. CME information and select publications here.…
  continue reading
 
Dr Loretta Nastoupil from The University of Texas MD Anderson Cancer Center in Houston, Texas, discusses recent advances and future directions in the treatment of patients with follicular lymphoma. CME information and select publications here.Av Research To Practice
  continue reading
 
Loading …

Hurtigreferanseguide

Copyright 2023 | Sitemap | Personvern | Vilkår for bruk